Artelo Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2014
Selling, General & Admin	4.23	5.96	4.6	2.77	0.95	Upgrade
Research & Development	5.7	4.32	2.84	1.92	1.09	Upgrade
Other Operating Expenses	0	0	0	0	1.17	Upgrade
Operating Expenses	9.93	10.29	7.44	4.69	3.21	Upgrade
Operating Income	-9.93	-10.29	-7.44	-4.69	-3.21	Upgrade
Interest Expense / Income	0	0.01	0	0	0	Upgrade
Other Expense / Income	-0.64	-0.21	-0	-0.03	-1.04	Upgrade
Pretax Income	-9.29	-10.08	-7.44	-4.66	-2.17	Upgrade
Net Income	-9.29	-10.08	-7.44	-4.66	-2.17	Upgrade
Shares Outstanding (Basic)	3	3	1	0	0	Upgrade
Shares Outstanding (Diluted)	3	3	1	0	0	Upgrade
Shares Change	4.48%	127.55%	403.69%	70.67%	70.05%	Upgrade
EPS (Basic)	-3.14	-3.56	-5.97	-18.90	-15.00	Upgrade
EPS (Diluted)	-3.14	-3.56	-5.97	-18.90	-15.00	Upgrade
Free Cash Flow	-8.21	-8.01	-6.14	-4.35	-2.79	Upgrade
Free Cash Flow Per Share	-2.77	-2.83	-4.93	-17.59	-19.29	Upgrade
EBITDA	-9.25	-10.04	-7.43	-4.66	-2.17	Upgrade
Depreciation & Amortization	0.04	0.04	0.01	0	0	Upgrade
EBIT	-9.29	-10.08	-7.44	-4.66	-2.17	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).